By Institutions

Publications - sorted by Institutions

• Hametner S, Silvaieh S, Thurnher M, Dal-Bianco A, Cetin H, Ponleitner M, Zebenholzer K, Pemp B, Trattnig S, Rössler K, Berger T, Lassmann H, Hainfellner J, Bsteh G (2022) A case of primary optic pathway demyelination caused by oncocytic oligodendrogliopathy of unknown origin Acta Neuropathologica Communications, 10 (1): 160

• Tobin W, Kalinowska-Lyszczarz A, Weigand S, Guo Y, Tosakulwong N, Parisi J, Metz I, Frischer J, Lassmann H, Brück W, Linbo L, Lucchinetti C (2021) Clinical Correlation of Multiple Sclerosis Immunopathologic Subtypes Neurology, 97(19): e1906-e1913
• Metz I, Gavrilova R, Weigand S, Frischer J, Popescu B, Guo Y, Gloth M, Tobin W, Zalewski N, Lassmann H, Tillema J, Erickson B, Parisi J, Becker S, König F, Brück W, Lucchinetti C (2021) MRI Correlates of Multiple Sclerosis Immunopathological Patterns Ann Neurol, 90(3): 440-454
• Tham M, Frischer J, Weigand S, Fitz‐Gibbon P, Webb S, Guo Y, Adiele R, Robinson C, Brück W, Lassmann H, Furber K, Pushie M, Parisi J, Lucchinetti C, Popescu B (2021) Iron heterogeneity in early active multiple sclerosis lesions Ann Neurol, 89(3): 498-510

• Popescu B, Frischer J, Webb S, Tham M, Adiele R, Robinson C, Fitz-Gibbon P, Weigand S, Metz I, Nehzati S, George G, Pickering I, Brück W, Hametner S, Lassmann H, Parisi J, Yong G, Lucchinetti C (2017) Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions Acta Neuropathol, 134 (1): 45-64

• Lampichler K, Ferrer P, Vila G, Lutz M, Wolf F, Knosp E, Wagner L, Luger A, Baumgartner-Parzer S (2015) The role of proto-oncogene GLI1 in pituitary adenoma formation and cell survival regulation Endocr Relat Cancer, 22 (5): 793-803
• Frischer J, Weigand S, Guo Y, Kale N, Parisi J, Pirko I, Mandrekar J, Bramow S, Metz I, Brück W, Lassmann H, Lucchinetti C (2015) Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque Ann Neurol, 78(5): 710-721

• Geißler A, Matt E, Fischmeister F, Wurnig M, Dymerska B, Knosp E, Feucht M, Trattnig S, Auff E, Fitch W, Robinson S, Beisteiner R (2014) Differential functional benefits of ultra highfield MR systems within the language network Neuroimage, 103: 163-170
• Dorfer C, Stefanits H, Pataraia E, Wolfsberger S, Feucht M, Baumgartner C, Czech T. (2014) Frameless Stereotactic Drilling for Placement of Depth Electrodes in Refractory Epilepsy: Operative Technique and Initial Experience. Neurosurgery,
• Goschzik T, zur Mühlen A, Kristiansen G, Haberler C, Stefanits H, Friedrich C, von Hoff K, Rutkowski S, Pfister S, Pietsch T (2014) Molecular stratification of medulloblastoma: Comparison of histological and genetic methods to detect Wnt activated tumors Neuropathol Appl Neurobiol,
• Stefanits H, Wesseling C, Kovacs G (2014) Loss of Calbindin immunoreactivity in the dentate gyrus distinguishes Alzheimer's disease from other neurodegenerative dementias Neurosci Lett, 566: 137-141
• Preusser M, Streubel B, Berghoff A, Hainfellner J, von Deimling A, Widhalm G, Dieckmann K, Wöhrer A, Hackl M, Zielinski C, Birner P (2014) Amplification and overexpression of CMET is a common event in brain metastases of non-small cell lung cancer Histopathology, 65 (5): 684-692

• Ilhan-Mutlu A, Wagner L, Widhalm G, Wöhrer A, Bartsch S, Czech T, Heinzl H, Leutmezer F, Prayer D, Marosi C, Base W, Preusser M (2013) Exploratory investigation of eight circulating plasma markers in brain tumor patients Neurosurg Rev, 36 (1): 45-56
• Wurnig M, Rath J, Klinger N, Höllinger I, Geissler A, Fischmeister F, Aichhorn M, Foki T, Kronbichler M, Nickel J, Siedentopf C, Staffen W, Verius M, Golaszewski S, Koppelstätter F, Knosp E, Auff E, Felber S, Seitz R, Beisteiner R (2013) Variability of Clinical Functional MR Imaging Results: A Multicenter Study Radiology, 268 (2): 521-531
• Berghoff AS, Stefanits H, Woehrer A, Heinzl H, Preusser M, Hainfellner JA (2013) Clinical neuropathology practice guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers. Clin Neuropathol, 3: 148-58

• Stefanits H, Czech T, Pataraia E, Baumgartner C, Derhaschnig N, Slana A, Kovacs GG. (2012) Prominent oligodendroglial response in surgical specimens of patients with temporal lobe epilepsy. Clin Neuropathol, 6
• Berghoff AS, Stefanits H, Heinzl H, Preusser M. (2012) Clinical Neuropathology Practice News 4-2012: levels of evidence for brain tumor biomarkers. Clin Neuropathol, 4: 206-9
• Stefanits H, Budka H, Kovacs G (2012) Asymmetry of neurodegenerative disease-related pathologies: a cautionary note Acta Neuropathol, 123 (3): 449-452
• Preusser M, Hassler M, Birner P, Rudas M, Acker T, Plate H, Widhalm G, Knosp E, Breitschopf H, Berger J, Marosi C. (2012) Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches Clin Neuropathol, 31(5): 352-360

• Roessler K, Donat M, Lanzenberger R, Novak K, Geissler A, Gartus A, Tahamtan AR, Milakara D, Czech T, Barth M, Knosp E, Beisteiner R. (2005) Evaluation of preoperative high magnetic field motor functional MRI (3 Tesla) in glioma patients by navigated electrocortical stimulation and postoperative outcome. J Neurol Neurosurg Psychiatry, 76(8): 1152-7